Micro Hospitals
Market Cap
₹1,455 ₹1,455 Cr.
P/E
37.01
PEG
0.80
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis comes live if hospital occupancy and patient-volume recovery materialize while MedTech approvals, supply-chain execution and customer conversion stay on schedule.

The bull path combines stronger hospital utilization with faster MedTech approvals and conversion; the bear path reflects failed occupancy recovery alongside regulatory and supply-chain delays.

Key Ratios

Debt to Equity
Debt to Equity
0.54
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
9.35 %
Institutions
Institutions
4.76 %
Market cap
Market cap
1,455 Cr
No. of Shareholders
No. of Shareholders
50,770
OPM (%)
OPM (%)
12.14 %
PE
PE
37.01
Prom Holding
Prom Holding
74.33 %
ROCE (%)
ROCE (%)
7.68
ROE (%)
ROE (%)
3.72
Sales
Sales
1,176 Cr
  • Shalby
  • KMC Speciality Hosp.
  • Dr Agarwals Eye Hosp
  • TJI Hospitals
Last updated on 12 Sep 2026
  • Shalby runs hospitals and makes orthopaedic implants through Shalby MedTech in India, the US and Singapore-Indonesia.
  • Hospitals provide most of its revenue. Government payers are 32% of the mix. The Gurugram unit serves international patients.
  • It entered Delhi-NCR in early 2024 by acquiring Sanar and Healers Hospital. The deals added the Gurugram unit and raised debt.
  • Hospitals drive profit. MedTech is the growth vector but EBITDA is still thin. Margins move with doctor costs.
  • It is building a 200-bed Mumbai hospital with ₹300Cr capex. It is adding global implant products for new markets.
  • Gurugram turned EBITDA break-even for the first time in Q1FY27. Hospital margin fell to 18.4% on new-doctor costs despite higher volumes.
  • Net debt is elevated and receivables have grown faster than revenue. Growth must still convert to cash.
  • Near-term profit depends on margin recovery and Gurugram ramp. Management guides hospital EBITDA margin up to 20% for FY27 and Gurugram PBT positive by Q3/Q4FY27.
  • Governance is an overhang after shareholders rejected a board-backed executive appointment. MedTech CEO succession is also open.
  • TPA renewals and bunker monetisation Q2FY27
    TPA renewals add 5–7% to TPA revenue. Bunker revenue starts to flow.
  • Shalby International ramp Q2–Q3FY27
    Gurugram moves toward ~30% occupancy and PBT positive by Q3/Q4FY27.
  • Receivables and leverage normalization next quarterly update
    Receivables stop growing faster than revenue.
  • MedTech scale-up and product launches FY27
    Shalby launches 3–4 products with 10–15% lower COGS and ₹3Cr monthly savings.
  • Mumbai Santacruz 200-bed project handover FY26–27 / Apr 2027; ops FY29–30
    The project adds 200 beds with ₹300Cr capex.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
126
52W Range
High
275
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

15 %
(as of Dec 22)
Joint Replacement Surgeries Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Customer Segment

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • Operational Beds (.)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Number of Outpatient Visits - Quarterly (.)
    • Number of Surgeries - Quarterly (.)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • ICE Make Refrigeration Ltd.

    FAQs on Shalby Ltd. Business

    Shalby Hospitals is a multispecialty hospital chain in India founded by Dr. Vikram Shah in 1994. With over 2000 hospital beds, it offers a wide range of specialized medical services under one roof, including joint replacement, neurology, cardiology, oncology, and more.

    Shalby major competitors are KMC Speciality Hosp., Dr Agarwals Eye Hosp, Aashka Hospitals, Fortis MalarHospital, Tejnaksh Healthcare, Global Longlife Hosp, Family Care Hospital.
    Market Cap of Shalby is ₹1,557 Crs.
    While the median market cap of its peers are ₹83 Crs.

    Shalby seems to be less financially stable compared to its competitors.
    Altman Z score of Shalby is 2.44 and is ranked 5 out of its 8 competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material